TOP > 外国特許検索 > METHOD FOR PRODUCING GELATINOUS COMPOSITION, AND GELATINOUS COMPOSITION

METHOD FOR PRODUCING GELATINOUS COMPOSITION, AND GELATINOUS COMPOSITION NEW

外国特許コード F210010303
整理番号 (S2019-0508-N0)
掲載日 2021年1月29日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2020JP025280
国際公開番号 WO 2020262625
国際出願日 令和2年6月26日(2020.6.26)
国際公開日 令和2年12月30日(2020.12.30)
優先権データ
  • 特願2019-119814 (2019.6.27) JP
発明の名称 (英語) METHOD FOR PRODUCING GELATINOUS COMPOSITION, AND GELATINOUS COMPOSITION NEW
発明の概要(英語) Provided is a method for producing a gelatinous composition, the method including: a step for mixing lecithin that has been dissolved or dispersed in water and an organic compound (excluding lecithin) having a molecular weight of 500 or more that has been dissolved or dispersed in water to obtain a mixed liquid containing the lecithin and the organic compound; a step for freeze-drying or heat-drying the mixed liquid to obtain a solid mixture containing the lecithin and the organic compound; and a step for mixing the solid mixture, an oil component and a polar liquid to obtain a gelatinous composition. Also provided is a gelatinous composition produced using the production method.
従来技術、競合技術の概要(英語) BACKGROUND ART
Because protein formulations are poorly absorbed from the gastrointestinal mucosa upon oral administration and degrade before being absorbed, most of the formulations have been developed as injectables that do not undergo first-pass effects. However, injectables also have many disadvantages such as being invasive, requiring the technique of a medicator, requiring sterile preparation, and the like.
Routes of administration that do not undergo first-pass effects include transdermal administration. Transdermal preparations have advantages such as simple administration methods, easy maintenance of blood levels, simple interruption of administration, and direct confirmation of medication compliance. However, the keratinous layer of the outermost layer of the skin is a strong barrier, and a water-soluble polymer having a molecular weight of 500 or greater is difficult to penetrate the skin. Therefore, preparations containing water-soluble polymers such as protein preparations cannot usually be administered as transdermal preparations.
Physical promotion methods such as microneedle methods and iontophoresis, nanoparticles, liposomes, surfactant vesicles, microemulsions, and the like have been investigated as methods for enhancing migration of drugs to the skin. Microneedle approach is a method of delivering drugs directly into the skin with fine needles, but is not painful compared to injections, but does not change in needle passage through the skin, which has problems with actual use, such as assurance of sterility. In addition, iontophoresis is a method of promoting absorption of drugs from the skin using electrical energy, but requires specialized devices and is suspected of effectiveness in polymers. In the method using nanoparticles, only appendages such as hair follicles and sweat glands are targeted because the nanoparticles are large to penetrate the stratum corneum. Liposomes have limited formulation in which it is difficult to efficiently and stably encapsulate the drug and can change shape so that it permeates between corner layers. Surfactant vesicles and microemulsions leave safety issues when the surfactant concentration is high or alcohol is needed.
On the other hand, gel-like formulations are widely used in various fields such as cosmetics, pharmaceuticals, foods, paints, inks, lubricants, and the like. There are various methods for preparing gel-like preparations, but the preparation of gel-like preparations by reverse string-like micelles has also been reported (NpL 1). A reversed string-like micelle is a type of self-assembly formed by a surfactant, and is known to induce gelation in order to form a network structure in oil.
The present inventors have found that in the past, lecithin/sucrose fatty acid ester (Patent Document 1), lecithin/saccharide (Patent Document 2), lecithin/urea (Patent Document 3), lecithin/polyglycerol (Patent Document 4); Gel-like compositions by reverse string-like micelles of lecithin/ascorbic acid or a derivative thereof (Patent Document 5) and lecithin/aliphatic carboxylic acid (Patent Document 6) have been developed. In addition, (Non-Patent Document 2) reports attempts to percutaneously absorb hydrophobic low molecules using gel-like compositions by reverse string-like micelles. In addition, the present inventors reported (Patent Document 7) a gel-like composition with enhanced skin migration properties of a water-soluble polymer having a molecular weight of 500 or greater by using reverse string-like micelles.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • NIHON UNIVERSITY
  • 発明者(英語)
  • HASHIZAKI Kaname
  • FUJII Makiko
  • TAGUCHI Hiroyuki
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DJ DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JO JP KE KG KH KN KP KR KW KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN WS ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL ST SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN TD TG
日本大学産官学連携知財センター(通称NUBIC,ニュービック)は,技術移転機関と知的財産本部の機能を兼ね備えた日本大学の産学連携の窓口です。
NUBICは,日本大学全教職員や大学院生・学部学生の豊富なアイデアや研究成果を,知的財産として戦略的に創出・保護・管理し,産業界のニーズとのマッチングを図り,企業の研究開発,新製品開発,新規事業の立上げが円滑に行われるようサポートいたします。
お気軽にご相談ください。

PAGE TOP

close
close
close
close
close
close